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Abstract
In this paper we describe the principles of polymerase chain reaction (PCR) and its expanding
use in molecular genetic research and molecular medicine. A short introduction of exemplary
applications of the PCR is connected with a discussion of the lack of PCR accuracy. We give
a statistical model for the PCR and discuss estimation methods in order to quantify the lack of
PCR accuracy.
Key words: Polymerase chain reaction, lack of PCR accuracy, branching process, estimation
of the mutation rate.
1. Introduction
The expanding use of polymerase chain reaction (PCR) in many fields of molecular genetic
research and molecular medicine implicates the analysis of the accuracy of the PCR.
Incorrect PCR products are useless for further applications and therefore a statistical analysis
of the PCR is of great interest. The amplification of DNA by this biochemical process consists
of iterative steps which form the chain reaction. Because this biochemical process produces
errors the PCR is not a deterministic process. Thus the stochastic character of the PCR bases
its statistical analysis using the theory of branching processes.
In this paper we focus on the stochastic modelling of the PCR considering the event of
mutation of DNA while performing this DNA amplification method which leads to incorrect
PCR products. The lack of accuracy of the PCR is obviously connected with the estimation of
mutation rates. Besides this, the amplification rate of the PCR can explain prior information
2for the estimation of mutation rate. Therefore, we discuss estimators of the mutation rate and
the amplification rate.
The importance of the PCR as a technique for gene analysis using gene markers is described
in section 2. In section 3 the principles of PCR are described. The stochastic modelling of
PCR, the estimators of the mutation rate and the amplification rate are discussed in section 4
and 5. Finally, applications of the PCR in the field of toxicokinetics are mentioned.
2. Molecular techniques for analysis of genes using genetic markers
Different types of DNA markers are used in genetic analysis. The markers segregate in
Mendelian fashion and enable gene tracking studies. The resulting genetic maps can be used
in the subsequent isolation of genes and in molecular genetic diagnosis.
The first markers to be developed were the sites that lead to the restriction fragment length
polymorphisms (RFLPs). Investigators in maize have shown that a potentially unlimited
number of RFLPs exists, which enable plant geneticists to establish genetic maps. These
developments have stimulated new statistical methodologies for locating individual loci that
control quantitative characters. Urfer et al. (1999) give a statistical strategy to analyze block
adjusted means of genotypes from α -designs and recommend an EM-algorithm for the
estimation of the genetic effect and the location of a quantitative trait locus.
Initiation and progression of a tumor is caused by alterations on the genomic levels. Genes
that inhibit tumor development and thus may contribute to tumorigenesis after loss or
inactivation are called tumor suppressor genes. The knowledge of a chromosomal region that
is frequently lost during the development of a distinct tumor type facilitate the identification
of yet unknown tumor suppressor genes. The detection of a lost chromosomal region is
experimentally performed by the analysis for the loss-of heterozygosity (LOH), i.e. the loss of
one out of two different allele-specific sequences. Therefore, a heterozygous sequence can
serve as a marker in the detection of LOHs and for the identification of novel tumor specific
genes. Such a heterozygous marker can be identified by analytical comparison of tumor DNA
with normal DNA using conventional methods.
An example for genetic markers, that are potentially useful for tumor diagnosis are the
microsatellite markers. These short sequence repeats show distinct and individual specific
3length and copy number throughout the genome, which might change during tumor
progression as a result of replication errors in the tumor cells. Thus, these markers represent
useful parameters in tumor diagnosis. Microsatellite fragments can be directly amplified by
special PCR methods what results in a specific microsatellite DNA patterns. Indeed, changes
in the patterns of microsatellite markers have been detected in the urine of bladder cancer risk
patients before the visualization of the tumors by conventional diagnostic methods.
3. The polymerase chain reaction
The polymerase chain reaction (PCR) first developed by Kary Mullis in 1985 (Saiki et al.,
1985) has entered all fields of molecular biology and molecular medicine. In this chapter the
principle of PCR is described, followed by a short introduction of exemplary PCR
applications and an outline of reasons for lacking of the essential accuracy.
 3.1 The principle
Generally, PCR is a simple in vitro method for the increase of the copy number of a DNA
fragment (Figure 1).
Figure 1. The principle of one PCR cycle. The strand separation is followed by the annealing of the two primers
which are enzymatically elongated. The resulting products are templates in the following cycles. By repetitive
cycles, the copy number is exponentially increased. The three steps differ by their different incubation
temperatures.
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4In the first step, the so-called template DNA, i.e. the DNA fragment that has to be amplified,
is denatured by increasing the incubation temperature. In this context denaturation means the
separation of the DNA double strands in two single strands. In the second step, the
temperature is lowered, where synthetically derived single-stranded oligonucleotides anneal
to sequences up- and downstream of the DNA fragment. The sequences of these primers
determine the annealing position and thus the sequence to be amplified. During the last step
the enzyme DNA polymerase elongates the annealed primers by incorporation of nucleotides
and synthesizing a new DNA strand that is complementary to the template sequence. These
three steps form one PCR cycle by which the original copy number of the DNA template is
doubled. By repetitive cycles the copy number can be exponentially increased by the factor
2n, where n is the number of cycles. For most applications n was empirically optimized as a
value between 25 and 35. In practice, the PCR process is simplified by the use of an
automated heat block.
In the following short summary, the components of a PCR sample are listed. Template DNA:
in diagnostic applications genomic or viral DNA; in research applications cloned genes or
gene fragments. Primers: synthetic single-stranded oligonucleotides, 18 to 30 nucleotides
long, which are complementary to sequences up- and down-stream of the fragment that has to
be amplified. Nucleotides: dATP, dCTP, dGTP, dTTP are the DNA building blocks which are
incorporated to elongate the primers and to synthesize the new DNA strand. DNA-
polymerase: catalyses the DNA synthesis. To simplify the technique, a heat stable enzyme is
used that is active over the repetitive cycles of increased heat incubation.
3.2 Exemplary PCR applications
The PCR technique is used in all projects when the DNA quantity is too low for analysis or
for further applications. Prominent examples of PCR applications include the molecular
diagnosis of tumors, the forensic person recognition and the discovery and manipulation of
new genes.
- Malignant cells differ from normal cells by distinct genomic alterations which might serve
as diagnostic parameters. The low amount of DNA in body fluids stemming from tumor
cells prohibit the direct detection of tumor specific mutations. The increase of the copy
number of the total DNA or the direct amplification of microsatellite markers by PCR
allows the detection of tumor DNA in sputum, urine or feces. Thereby, tumors of the lung,
the bladder or the colon can be diagnosed, respectively (Deuter und Müller, 1998). In the
5near future, these non-invasive techniques will at least complement the classic methods of
cancer diagnosis.
- During most punishable acts, the offenders loose cells (e.g. skin, blood, hair) at the sites of
crime. From these cells, DNA can be amplified and analyzed by simple PCR methods to
receive an individual-specific DNA fingerprint. This fingerprint is compared with the
fingerprints of suspects to identify the potential criminal. Today, the forensic area is the
field with the second most PCR applications.
- All levels of molecular genetic research have been influenced by PCR. PCR applications
reach from the replacement or the simplification of time consuming and error-prone gene
cloning to special PCR methods which are used to alter the sequence or length of a gene.
3.3 Practical reasons for the lack of PCR accuracy
The expanding use of PCR in all fields of molecular genetic research and molecular medicine
makes essential an experimental and theoretical unfolding of possible sensitivities. The most
interesting aspect is the accuracy of the PCR, i.e. the consistence between the synthesized and
template sequences. It is obvious that the highest possible accuracy during the DNA synthesis
is necessary since low accuracy during the polymerization leads to mutations in the resulting
product. A PCR product with mutations is useless for further applications and does not allow
any conclusions regarding the template DNA of interest. Known experimental parameters
with influence on the PCR mutation rate are: the enzyme, the buffer composition, and the
temperature of primer annealing.
- The enzyme is the most important parameter that influences the PCR mutation rate. The
best choice is an enzyme with proof reading activity, i.e. an enzyme that is able to correct
its own sequence errors. Usually, these enzymes synthesize DNA with an error-rate of less
than 1 mutation in 105 nucleotides compared to an error rate of 1 of 103 of an enzyme
without proofreading activity.
- Many metal ions or organic compounds in the buffer (e.g. Mg2+, DMSO), show influence
on the DNA polymerase and its degree of accuracy. Thus, several authors recommend the
titration of these components in order to optimize the conditions before starting a new
PCR reaction.
- Last, the primer annealing position on the template DNA is crucial for specificity and
accuracy of the PCR. The incubation at a temperature below the primer-specific annealing
6temperature may lead to unspecific annealing and may be followed by the amplification of
an unwanted DNA fragment.
4. Branching processes for modelling polymerase chain reactions
The theory of branching processes bases various stochastic models for polymerase chain
reaction (Krawczak et al. 1989, Sun, 1995, and Peccoud and Jacob, 1998). In Krawczak et al.
(1989) a branching process is used to analyse the impact of replication errors on the reliability
of PCR. A stochastic model using the branching process in order to estimate the mutation rate
of the PCR is described in Sun (1995). Peccoud and Jacob (1998) proposed an estimator for
the amplification rate of the quantitative PCR using branching processes with migration. Both
the quantitative PCR and the estimation of PCR mutation rates lead to the statistical analysis
of PCR accuracy.
In order to define a special branching process with discrete time for stochastic modelling of
PCR the following notation is necessary:
Let n denote the total number of PCR cycles and let Si denote the number of identically
copied sequences of a single-stranded DNA after i PCR cycles, i=1, ..., n. Then the original
sequences can be defined as the 0th generation sequences. The sequences generated directly
from the original sequences are defined as 1st generation sequences and inductively the
sequences generated directly from the (k-1)-th generation are defined as k-th generation
sequences, k=1, .... ,n. Furthermore nkX denotes the number of identically copied sequences
of the k-the generation after n PCR cycles and nkX defines a random variable. A fraction λ
of sequences that serves as DNA-templates for identical copies is called the efficiency of
PCR. Moreover, let λ define as a constant in the whole PCR.  From this follows that for all k,
k=0 ,..., n , the behaviour of a certain k-th generation sequence in a certain PCR cycle does
not depend on the behaviour of all other sequences in the same PCR cycle. Therefore the
branching property referring to the events of identical copy or no identical copy can be
assumed. Then the total number of identically copied sequences after n PCR cycles, 1n ≥ , is
given by:
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The sequence ,....,, 210 SSS defines a branching process with discrete time a so-called
Galton-Watson-process.
The PCR enables the assumption of the Markov property. Thereby the transition probabilities
only depend on the realised event of the direct former PCR cycle. Therefore the defined
Galton-Watson-process can also be interpreted as a special Marcov chain. The following
figure demonstrates a realisation of the defined branching process with S0=1.
Figure 1: A branching process for two PCR cycles with one original sequence. The
generated sequences and the original sequences remain with probability 1 in the PCR.
Every sequence is denoted by indexes in order to identify the sequences in the process. The
first index denotes the generation of the sequence and the second index denotes the number of
the copied sequences of a certain generation. If we consider the realisation in figure 1 it is
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Therefore the following results for the mean of Sn and the mean of nkX are important for a
further analysis of the defined branching process:
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The probability generating function of S1 is defined as
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By the property of the probability function referring to a branching process
(Harris, 1963) it is:
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Considering S0 branching processes with an initial number of one original
sequences leads to (3). ◊
The proof of (4) is described in Sun (1995).
9The events identical copy or no identical copy enable a statistical analysis neglecting the
knowledge of mutation. But a mutation can be one reason for the event of no identical copy
and therefore the consideration of the distribution of mutations enables a more detailed
statistical analysis.
In Sun (1995) further assumptions referring to the distribution of mutations are made:
(A1) The event of a mutation in one sequence can be assumed as randomly and rare. Then
the distribution of the number of mutation can be assumed Poisson with parameter
µ (mutation rate).
(A2) The length G (for example the number of bases) of a sequence influences the
probability of a mutation.
(A3) The number of mutations in one sequence depends on the generation K of a sequence.
For example after 2 PCR cycles there can be two mutations on the same sequence.
Assuming (A1) - (A3) the conditional probability density of the number M of mutations on a
sequence is as follows:
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By applying the results (3) and (4) Sun (1995) showed that the distribution of the generation
K of one sequence is approximately binomial with probability λ
λ
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. This is a result of strong
law of large numbers. Combining (5) and the approximated (for large S0 ) distribution of K
Sun (1995) yield the following results for the distribution of M.
(i.) The probability density is:
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The proofs of (i.) - (iii.) are described in Sun (1995). The approximations of the distribution
of M are also investigated by Sun (1995). These examinations show that the normal
approximation was better than the Poisson approximation for large Gnµ and that the Poisson
approximation almost coincided with the actual distribution after 20 or 50 PCR
cycles, 40/1=Gµ and 9.0=λ .
It is of great interest how far the assumptions (A1) - (A3) are recorded by the proposed result
in (i.). Therefore Sun (1995) computed the probability P(M=m) as it is given in (i) for
different values of G and n.  These computations justify the proposed model because they
show that by increasing G the probability of mutation increases, too. The same result was
found for increasing number of  PCR cycles. Moreover,  the examinations showed that the
distribution of M did not change with efficiency of PCR very much.
A supplement to the examination of Sun (1995) is the examination of the behaviour of the
distribution of M referring to different mutation rates µ .
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m
(number
of
mutations)
5109 −⋅=µ 410−=µ 4101.1 −⋅=µ 4102 −⋅=µ
0 0.5316 0.4960 0.4629 0.2506
1 0.3319 0.3432 0.3513 0.3375
2 0.1002 0.1148 0.1289 0.2197
3 0.0097 0.0124 0.0152 0.0460
4 0.0002 0.0003 0.0004 0.0023
Table 1: The probability of the number of mutation in a randomly chosen sequence after
30 PCR cycles with a sequence length G=500 and an efficiency of PCR 9.0=λ .
Table 1 shows the change of the distribution of M with mutation rate µ . A 10%-deviation  of
µ causes a deviation of 10 % referring to the probability of the number of no mutation and
doubling µ causes halving P(M=0). As these results have to be expected  they are a further
validation of the model of  Sun (1995).
5. Estimation of parameters
As it is discussed in section 4 the mutation rate µ and the amplification rate of PCR are
important parameters in the statistical analysis of PCR accuracy. In this section two estimators
of µ proposed by Sun (1995) and one estimator of the amplification rate of PCR proposed by
Peccoud and Jacob (1998) are described.
After one PCR a sample M1,....,Mr of mutation numbers on randomly chosen sequences can
be drawn. Due to the results of section 4 all Mi, i=1,...,r have identical distribution with mean
E[M1]= λ
λµ
+1
Gn
. By applying the moment estimation method Sun (1995) gives the following
unbiased estimator of µ :
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Sun (1995) showed that the standard deviation of µˆ is approximately:
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Before computing this estimator two problems have to be carried. First λ is unknown and
therefore λ has to be estimated. Second the mutation numbers are only available if the whole
sequence is known. Carrying the second problem Sun (1995) proposed an estimator using the
Hamming distance between two sequences. The Hamming distance is defined as the pairwise
distance between two sequences (Sun, 1995). Both sequences are correlated through a
branching process and the estimator of mutation rate is:
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Hi,j denotes the Hamming distance between a sequence i and a sequence j of a sample of r
sequences. Deducing of µ~ is also described in detail in Sun (1995). Nevertheless, the
problem of estimation of λ is not carried.
In Peccoud and Jacob (1998) an estimator of the amplification rate mamp is proposed. The
amplification rate in a deterministic model of PCR is 2 if every sequence is copied identically.
Then the deterministic number of PCR products after n PCR cycles is Sn=2nS0. But
considering the stochastic character of PCR the amplification rate must have a distribution on
the interval [1,2] which includes the theoretical cases mamp=1 (PCR is not able to copy any
sequence) and mamp=2 (PCR is a biochemical process without producing errors).
The following estimator of the amplification rate depending on the number of PCR products
of the last three PCR cycles  is proposed by Peccoud and Jacob (1998):
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This estimator is deduced by Jacob and Peccoud (1996) applying a branching process with
migration.
Approximately the efficiency of PCR and the amplification rate of PCR are connected by the
following equation: λ+= 1ampm .
Now it is possible to quantify λ by the estimation of mamp
But a simple combination of the estimations methods (6), (7) and (8) of both parameters is not
possible. Measuring data in order to estimate the amplification rate requires a completley
different design of experiment than measuring data in order to estimate the mutation rate and
lead to complex data structures. Furthermore, the simulations in Peccoud and Jacob (1998)
showed that the estimators of mamp consisting of data of a few PCR cycles are not stable and
especially the data of PCR’s with low initial numbers S0 enforce the use of confidence
intervals for mamp. Moreover, taking into account the results of Peccoud and Jacob (1998) the
Markov property of the described branching process in section 4 has to be discussed. This
leads to further assumptions referring to λ especially the assumption of no constancy of λ .
6. Applications of polymerase chain reactions in risk assessment of potential
carcinogens
The estimation of toxicokinetic parameters plays a fundamental role in the risk assessment of
potential carcinogens. Urfer and Becka (1996) and Golka et al. (1999) modelled the process
of chemical carcinogens into chemical active metabolites, that are able to interact with
cellular macromolecules such as DNA, RNA and protein. The nonlinearity between applied
dose and tumor response is supposed to be connected with the processes involved in the
formation of DNA adducts. Selinski (2000) investigates the interindividual and interoccasion
variabilities of toxicokinetic parameters relevant for the carcinogenicity of ethylene using an
EM-algorithm.
Acrylonitrile (AN) and ethylene oxide (EO) are industrially important carcinogenic C2-
compounds whose genotoxicity is viewed in connection with their ability to bind to
macromolecular targets. Both compounds are reactive towards glutathione and are detoxified
via glutathione transferases (GST). Thier et al. (1999) performed a haemoglobin adduct
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monitoring of fifty-nine persons with industrial handling of low levels of AN. The genetic
states of the polymorphic glutathione transferases GSTM1 and GSTT1 were assayed by
polymerase chain reaction. A 480 bp fragment of the human GSTT1 gene was amplified with
the primers 5’ - TTC CTT ACT GGT CCT CAC ATC TC - 3’ and 5’ - TCA CCG GAT CAT
GGC CAG CA - 3’. Details of the PCR reactions are given by Thier et al. (1999). The data
analysis suggests that the lower EO detoxification rate in GSTT1-persons, indicated by
elevated blood protein hydroxyethyl adduct levels, leads to an increased genotoxic effect of
the EO background.
Further statistical methods as Kalman filter and neural network methodology used by Urfer
and Schmitz (1997) and Guimaraes (1999) can be used to improve DNA sequencing
accuracy. Nelson (1996) describes some efforts towards this important problem.
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